CLOVER HEALTH INV. CL.A
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It operates Clover Assistant, a software platform to execute strategy by enabling physicians to detect, identify, and manage chronic diseases earlier than they otherwise could. The co… Read more
Market Cap & Net Worth: CLOVER HEALTH INV. CL.A (7QD)
CLOVER HEALTH INV. CL.A (F:7QD) has a market capitalization of $718.42 Million (€699.89 Million) as of March 19, 2026. Listed on the F stock exchange, this Germany-based company holds position #8841 globally and #947 in its home market, demonstrating a -1.17% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CLOVER HEALTH INV. CL.A's stock price €1.65 by its total outstanding shares 424304898 (424.30 Million).
CLOVER HEALTH INV. CL.A Market Cap History: 2021 to 2026
CLOVER HEALTH INV. CL.A's market capitalization history from 2021 to 2026. Data shows change from $1.41 Billion to $718.42 Million (-33.51% CAGR).
CLOVER HEALTH INV. CL.A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CLOVER HEALTH INV. CL.A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 7QD by Market Capitalization
Companies near CLOVER HEALTH INV. CL.A in the global market cap rankings as of March 19, 2026.
Key companies related to CLOVER HEALTH INV. CL.A by market ranking:
- UnitedHealth Group Incorporated (NYSE:UNH): Ranked #56 globally with a market cap of $256.27 Billion USD.
- CVS Health Corp (NYSE:CVS): Ranked #214 globally with a market cap of $94.98 Billion USD.
- Cigna Corp (NYSE:CI): Ranked #303 globally with a market cap of $71.15 Billion USD.
- Elevance Health Inc (NYSE:ELV): Ranked #343 globally with a market cap of $63.54 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #56 | UnitedHealth Group Incorporated | NYSE:UNH | $256.27 Billion | $287.57 |
| #214 | CVS Health Corp | NYSE:CVS | $94.98 Billion | $74.81 |
| #303 | Cigna Corp | NYSE:CI | $71.15 Billion | $263.47 |
| #343 | Elevance Health Inc | NYSE:ELV | $63.54 Billion | $295.75 |
CLOVER HEALTH INV. CL.A Historical Marketcap From 2021 to 2026
Between 2021 and today, CLOVER HEALTH INV. CL.A's market cap moved from $1.41 Billion to $ 718.42 Million, with a yearly change of -33.51%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €718.42 Million | -19.22% |
| 2025 | €889.37 Million | -32.81% |
| 2024 | €1.32 Billion | +251.49% |
| 2023 | €376.57 Million | +2.83% |
| 2022 | €366.20 Million | -74.09% |
| 2021 | €1.41 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of CLOVER HEALTH INV. CL.A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $718.42 Million USD |
| MoneyControl | $718.42 Million USD |
| MarketWatch | $718.42 Million USD |
| marketcap.company | $718.42 Million USD |
| Reuters | $718.42 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.